9:@0.890196:0.957873:0.898787:0.957873:0.898787:0.938882:0.890196:0.938882:0.008591
1:@0.941813:0.186378:0.963291:0.186378:0.963291:0.138900:0.941813:0.138900:0.021478
introduction:@0.794874:0.064721:0.882352:0.064721:0.882352:0.047603:0.794874:0.047603:0.003511:0.008759:0.006387:0.008311:0.008442:0.008423:0.008367:0.008178:0.006387:0.003511:0.008442:0.008759
Tumor:@0.315443:0.372905:0.391857:0.372905:0.391857:0.350290:0.315443:0.350290:0.014792:0.014512:0.022159:0.015378:0.009573
Cell lines:@0.219941:0.476966:0.323816:0.476966:0.323816:0.454351:0.219941:0.454351:0.019787:0.014875:0.005498:0.005498:0.004438:0.005498:0.005330:0.014736:0.014875:0.013340
Xenografts:@0.437459:0.477797:0.566734:0.477797:0.566734:0.455181:0.437459:0.455181:0.016215:0.014847:0.014708:0.015350:0.015126:0.009015:0.014205:0.007929:0.008540:0.013340
Organoids:@0.685984:0.476966:0.810372:0.476966:0.810372:0.454351:0.685984:0.454351:0.021769:0.009015:0.015154:0.014233:0.014736:0.015378:0.005330:0.015433:0.013340
Cancer cell death:@0.439943:0.153099:0.644428:0.153099:0.644428:0.130484:0.439943:0.130484:0.019787:0.014233:0.014736:0.014484:0.014875:0.009573:0.004438:0.014484:0.014875:0.005498:0.005498:0.004438:0.015433:0.014875:0.013954:0.008568:0.014736
Bloodstream:@0.649368:0.304486:0.800939:0.304486:0.800939:0.281871:0.649368:0.281871:0.017973:0.005498:0.015378:0.015378:0.015433:0.013061:0.008568:0.009015:0.014875:0.014233:0.022159
cfDNA:@0.756229:0.186488:0.835433:0.186488:0.835433:0.163873:0.756229:0.163873:0.014484:0.008205:0.019089:0.019341:0.018085
ctDNA:@0.757011:0.232845:0.836578:0.232845:0.836578:0.210230:0.757011:0.210230:0.014484:0.008568:0.019089:0.019341:0.018085
A:@0.419470:0.140048:0.439620:0.140048:0.439620:0.111739:0.419470:0.111739:0.020150
B:@0.201888:0.439086:0.222038:0.439086:0.222038:0.410778:0.201888:0.410778:0.020150
Figure 2: Origin of ctDNA and different cancer models. (A):@0.147059:0.579348:0.588718:0.579348:0.588718:0.562057:0.147059:0.562057:0.009488:0.005080:0.008797:0.009730:0.006761:0.007751:0.004987:0.008927:0.004445:0.004987:0.013578:0.006929:0.005080:0.008757:0.005080:0.009955:0.004987:0.009264:0.005678:0.004987:0.007639:0.005939:0.013148:0.012233:0.012345:0.004987:0.007900:0.009955:0.009712:0.004987:0.009712:0.005080:0.005248:0.004800:0.007583:0.006761:0.007583:0.009861:0.005939:0.004987:0.007695:0.007900:0.009955:0.007433:0.007583:0.007022:0.004987:0.014810:0.009618:0.009786:0.007601:0.004725:0.006649:0.004445:0.004987:0.006238:0.012345:0.006238
 Dying cells from a tumor, in this case an :@0.588751:0.579348:0.885670:0.579348:0.885670:0.562679:0.588751:0.562679:0.005099:0.013596:0.007956:0.004594:0.009376:0.008068:0.005099:0.007359:0.007321:0.004408:0.004296:0.006275:0.005099:0.005248:0.006089:0.008871:0.014437:0.005099:0.007601:0.005099:0.005043:0.009338:0.014306:0.008871:0.005117:0.003679:0.005099:0.004594:0.009618:0.005099:0.005416:0.009376:0.004594:0.006275:0.005099:0.007452:0.007601:0.006443:0.007396:0.005099:0.007433:0.009618:0.003362
ovarian tumor, release their fragmented genomic material to the bloodstream. Circulating tumor DNA :@0.147059:0.593900:0.885715:0.593900:0.885715:0.577231:0.147059:0.577231:0.008890:0.008050:0.007433:0.006387:0.004744:0.007433:0.009618:0.005947:0.005043:0.009338:0.014306:0.008871:0.005117:0.003679:0.005948:0.006089:0.007321:0.004240:0.007599:0.007601:0.006443:0.007396:0.005948:0.005416:0.009245:0.007396:0.004594:0.006387:0.005947:0.005248:0.006462:0.007525:0.008068:0.014308:0.007396:0.009320:0.005080:0.007452:0.009320:0.005947:0.007900:0.007396:0.009488:0.008871:0.014437:0.004538:0.007359:0.005947:0.014381:0.007209:0.005080:0.007396:0.006387:0.004744:0.007695:0.004296:0.005947:0.005080:0.009039:0.005947:0.005416:0.009245:0.007396:0.005948:0.008927:0.004240:0.009226:0.009224:0.009320:0.006146:0.005267:0.006089:0.007599:0.007433:0.014437:0.003679:0.005948:0.011953:0.004594:0.006090:0.007450:0.009450:0.004445:0.007209:0.005267:0.004594:0.009376:0.008068:0.005948:0.005043:0.009338:0.014306:0.008871:0.006387:0.005947:0.012905:0.012607:0.012214:0.003362
(ctDNA) carries all the genomic alterations present in the tumor, and can be used as a proxy to estimate :@0.147059:0.608452:0.885711:0.608452:0.885711:0.591783:0.147059:0.591783:0.005678:0.007452:0.005267:0.012905:0.012607:0.012214:0.005678:0.005005:0.007452:0.007433:0.006387:0.006387:0.004537:0.007396:0.006275:0.005005:0.007695:0.004408:0.004296:0.005005:0.005416:0.009245:0.007396:0.005005:0.007900:0.007396:0.009488:0.008871:0.014437:0.004538:0.007359:0.005005:0.007695:0.004015:0.005080:0.007396:0.006462:0.007209:0.005267:0.004538:0.008871:0.009506:0.006275:0.005005:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005267:0.005005:0.004594:0.009618:0.005005:0.005416:0.009245:0.007396:0.005005:0.005043:0.009338:0.014306:0.008871:0.005117:0.003679:0.005005:0.007433:0.009488:0.009320:0.005005:0.007452:0.007433:0.009618:0.005005:0.009207:0.007396:0.005005:0.009338:0.006443:0.007452:0.009320:0.005005:0.007601:0.006275:0.005005:0.007601:0.005005:0.009058:0.006089:0.008853:0.008255:0.007956:0.005005:0.005080:0.009039:0.005005:0.007396:0.006145:0.005267:0.004594:0.014381:0.007209:0.005080:0.007396:0.003362
tumor presence and dynamics. Cell-free DNA (cfDNA), which originates from other normal cells, is also :@0.147059:0.623004:0.885748:0.623004:0.885748:0.606335:0.147059:0.606335:0.005043:0.009338:0.014306:0.008871:0.006387:0.004650:0.009058:0.006089:0.007396:0.006443:0.007396:0.009488:0.007359:0.007396:0.004650:0.007433:0.009488:0.009320:0.004650:0.009264:0.007956:0.009562:0.007433:0.014437:0.004538:0.007359:0.006275:0.003679:0.004650:0.012270:0.007321:0.004408:0.004296:0.006163:0.005248:0.006089:0.007452:0.007396:0.004650:0.012904:0.012607:0.012214:0.004650:0.005678:0.007359:0.005080:0.012905:0.012607:0.012214:0.005678:0.003679:0.004650:0.012102:0.009376:0.004538:0.007172:0.009376:0.004650:0.008871:0.006387:0.004594:0.008068:0.004594:0.009562:0.007209:0.005080:0.007396:0.006275:0.004650:0.005246:0.006089:0.008873:0.014437:0.004650:0.008853:0.005416:0.009245:0.007396:0.006387:0.004650:0.009488:0.008871:0.006387:0.014381:0.007695:0.004296:0.004650:0.007359:0.007321:0.004408:0.004296:0.006275:0.003679:0.004650:0.004594:0.006275:0.004650:0.007695:0.004296:0.006443:0.009039:0.003362
present in the bloodstream. :@0.147059:0.637556:0.344320:0.637556:0.344320:0.620887:0.147059:0.620887:0.009058:0.006089:0.007396:0.006443:0.007396:0.009320:0.005267:0.005024:0.004594:0.009618:0.005024:0.005416:0.009245:0.007396:0.005024:0.008927:0.004240:0.009226:0.009226:0.009320:0.006145:0.005267:0.006089:0.007601:0.007433:0.014437:0.003679:0.003362
(B) :@0.345972:0.637556:0.372997:0.637556:0.372997:0.620265:0.345972:0.620265:0.006238:0.011262:0.006238:0.003287
The main patient-derived cancer models include: i) 2D cell cultures that :@0.374620:0.637556:0.885737:0.637556:0.885737:0.620887:0.374620:0.620887:0.009385:0.009254:0.007396:0.005024:0.014381:0.007433:0.004594:0.009618:0.005024:0.009299:0.007209:0.005267:0.004538:0.007396:0.009320:0.005267:0.006163:0.009264:0.007396:0.006387:0.004538:0.007881:0.007452:0.009320:0.005024:0.007452:0.007433:0.009488:0.007359:0.007396:0.006387:0.005024:0.014306:0.009226:0.009264:0.007321:0.004296:0.006275:0.005024:0.004594:0.009488:0.007172:0.004015:0.009282:0.009264:0.007396:0.003679:0.005024:0.004594:0.005678:0.005024:0.008535:0.013204:0.005024:0.007359:0.007321:0.004408:0.004296:0.005024:0.007452:0.009450:0.004015:0.005043:0.009338:0.006089:0.007396:0.006275:0.005024:0.005416:0.009320:0.007209:0.005267:0.003362
are easy to maintain, manipulate and expand but often do not recapitulate some tumor characteristics, :@0.147059:0.652108:0.885657:0.652108:0.885657:0.635439:0.147059:0.635439:0.007433:0.006089:0.007396:0.006014:0.007601:0.007601:0.006350:0.007956:0.006014:0.005080:0.009039:0.006014:0.014381:0.007433:0.004594:0.009320:0.005360:0.007433:0.004594:0.009618:0.003679:0.006014:0.014381:0.007433:0.009618:0.004314:0.009039:0.009450:0.004445:0.007209:0.005080:0.007396:0.006014:0.007433:0.009488:0.009320:0.006014:0.007452:0.008255:0.009301:0.007433:0.009488:0.009320:0.006014:0.008834:0.009058:0.005267:0.006014:0.008871:0.005071:0.004884:0.007396:0.009618:0.006014:0.009264:0.009039:0.006014:0.009490:0.008853:0.005267:0.006014:0.006089:0.007452:0.007450:0.007211:0.009058:0.004312:0.005043:0.009450:0.004445:0.007209:0.005080:0.007396:0.006014:0.006443:0.008871:0.014306:0.007396:0.006014:0.005043:0.009338:0.014306:0.008871:0.006387:0.006014:0.007172:0.009320:0.007435:0.006460:0.007601:0.007452:0.005080:0.007396:0.006387:0.004594:0.006145:0.005267:0.004538:0.007359:0.006275:0.003679:0.003362
especially after extensive culturing. ii) Xenografts (PDXs), generated by transplantation of tumor cells in :@0.147059:0.666660:0.885715:0.666660:0.885715:0.649991:0.147059:0.649991:0.007396:0.006145:0.009413:0.007452:0.007359:0.004744:0.007693:0.004408:0.004240:0.007956:0.005276:0.007433:0.005071:0.004884:0.007396:0.006387:0.005276:0.007452:0.008255:0.005080:0.007396:0.009506:0.006219:0.004538:0.007881:0.007396:0.005276:0.007452:0.009450:0.004015:0.005043:0.009338:0.006387:0.004594:0.009376:0.007919:0.003679:0.005274:0.004594:0.004594:0.005678:0.005276:0.011299:0.007396:0.009488:0.009039:0.008068:0.006462:0.007433:0.005071:0.005071:0.006275:0.005276:0.005678:0.009544:0.012588:0.011542:0.006275:0.005678:0.003679:0.005274:0.007900:0.007396:0.009488:0.007396:0.006462:0.007209:0.005080:0.007452:0.009320:0.005276:0.008871:0.007956:0.005276:0.005267:0.006462:0.007433:0.009506:0.006145:0.009133:0.004445:0.007433:0.009320:0.005360:0.007209:0.005267:0.004538:0.008871:0.009618:0.005276:0.008871:0.005080:0.005276:0.005043:0.009338:0.014306:0.008871:0.006387:0.005276:0.007359:0.007321:0.004406:0.004296:0.006275:0.005276:0.004594:0.009618:0.003362
immunocompromised mice. They recapitulate tumor characteristics better :@0.147059:0.681212:0.669438:0.681212:0.669438:0.664543:0.147059:0.664543:0.004594:0.014437:0.014138:0.009338:0.009488:0.009226:0.007359:0.008871:0.014138:0.009058:0.006089:0.008871:0.014437:0.004594:0.006443:0.007452:0.009320:0.004426:0.014437:0.004538:0.007359:0.007153:0.003679:0.004426:0.009385:0.009254:0.007639:0.007956:0.004426:0.006089:0.007452:0.007450:0.007209:0.009058:0.004314:0.005043:0.009450:0.004445:0.007209:0.005080:0.007396:0.004426:0.005043:0.009338:0.014306:0.008871:0.006387:0.004426:0.007172:0.009320:0.007435:0.006460:0.007601:0.007452:0.005080:0.007396:0.006387:0.004594:0.006145:0.005267:0.004538:0.007359:0.006275:0.004426:0.009207:0.007471:0.005043:0.005080:0.007396:0.006387:0.003362
in vivo:@0.670521:0.681212:0.715868:0.681212:0.715868:0.664371:0.670521:0.664371:0.004165:0.009245:0.004520:0.007601:0.004221:0.007471:0.008124
, but they are costly and :@0.715875:0.681212:0.885700:0.681212:0.885700:0.664543:0.715875:0.664543:0.003679:0.004426:0.008834:0.009058:0.005267:0.004426:0.005416:0.009245:0.007639:0.007956:0.004426:0.007433:0.006089:0.007396:0.004426:0.007359:0.008963:0.006146:0.005416:0.004240:0.007956:0.004426:0.007433:0.009488:0.009320:0.003362
low-throughput. iii) Organoids (PDOs), which are 3D cultures of tumor cells that recapitulate faithfully :@0.147059:0.695764:0.885747:0.695764:0.885747:0.679096:0.147059:0.679096:0.004240:0.008890:0.012046:0.006163:0.005416:0.009376:0.006089:0.008853:0.009338:0.008124:0.009077:0.009039:0.009058:0.005267:0.003679:0.005528:0.004594:0.004594:0.004594:0.005678:0.005528:0.013335:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.006275:0.005528:0.005678:0.009544:0.013503:0.013298:0.006275:0.005678:0.003679:0.005528:0.012102:0.009376:0.004537:0.007172:0.009376:0.005528:0.007433:0.006089:0.007396:0.005528:0.008535:0.013204:0.005528:0.007452:0.009450:0.004014:0.005045:0.009338:0.006089:0.007396:0.006275:0.005528:0.008871:0.005080:0.005528:0.005043:0.009338:0.014306:0.008871:0.006387:0.005528:0.007359:0.007321:0.004408:0.004296:0.006275:0.005528:0.005416:0.009321:0.007207:0.005267:0.005528:0.006089:0.007452:0.007452:0.007209:0.009058:0.004314:0.005043:0.009450:0.004445:0.007209:0.005080:0.007396:0.005528:0.005080:0.007435:0.004312:0.005416:0.009376:0.005209:0.009450:0.004408:0.004240:0.007956:0.003362
the original tumor and are suitable for high-throughput applications such as drug screening or genetic :@0.147059:0.710316:0.885711:0.710316:0.885711:0.693648:0.147059:0.693648:0.005416:0.009245:0.007396:0.005995:0.008871:0.006387:0.004594:0.008068:0.004594:0.009562:0.007695:0.004296:0.005995:0.005043:0.009338:0.014306:0.008871:0.006387:0.005995:0.007433:0.009488:0.009320:0.005995:0.007433:0.006089:0.007396:0.005995:0.006145:0.009338:0.004312:0.005360:0.007452:0.008927:0.004240:0.007396:0.005995:0.004931:0.008871:0.006387:0.005995:0.009376:0.004594:0.008124:0.009376:0.006163:0.005416:0.009376:0.006089:0.008853:0.009338:0.008124:0.009077:0.009039:0.009058:0.005267:0.005995:0.007209:0.009039:0.009133:0.004296:0.004538:0.007452:0.007209:0.005267:0.004538:0.008871:0.009506:0.006275:0.005995:0.006145:0.009282:0.007172:0.009376:0.005995:0.007601:0.006275:0.005995:0.009320:0.006518:0.009338:0.008068:0.005995:0.006443:0.007359:0.006089:0.007452:0.007396:0.009618:0.004594:0.009376:0.008068:0.005995:0.008871:0.006387:0.005995:0.007900:0.007396:0.009488:0.007471:0.005267:0.004538:0.007359:0.003362
manipulation. Figure created with BioRender. :@0.147059:0.724868:0.465134:0.724868:0.465134:0.708200:0.147059:0.708200:0.014381:0.007433:0.009618:0.004314:0.009039:0.009450:0.004445:0.007209:0.005267:0.004538:0.008871:0.009618:0.003679:0.003362:0.009320:0.004594:0.008068:0.009338:0.006087:0.007396:0.003362:0.007359:0.006089:0.007601:0.007209:0.005080:0.007452:0.009320:0.003362:0.012046:0.004312:0.005418:0.009376:0.003362:0.010214:0.004538:0.009039:0.011206:0.007396:0.009488:0.009264:0.007396:0.005117:0.003679:0.003362